Kaliumklorid Sad

Potassium chloride, the active ingredient in Kaliumklorid Sad, is an electrolyte supplement presented as a sterile solution for injection for intravenous use. It is employed to treat potassium depletion and hypokalemia in patients who require rapid potassium repletion.

GNH USA supplies Kaliumklorid Sad as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres and pharmacies worldwide. The product is manufactured in the European Union under strict GMP standards and is distributed globally to meet clinical demand safely.

Kaliumklorid Sad is used to correct electrolyte disturbances associated with low potassium levels.

Hypokalemia: restores serum potassium to normal range, alleviating muscle weakness and cardiac conduction abnormalities. Potassium depletion during diuretic therapy: replenishes total body potassium stores to prevent further electrolyte imbalance. Risk of cardiac arrhythmia due to hypokalemia: normalizes myocardial excitability, reducing the likelihood of arrhythmic events.

Potassium chloride injection may be associated with several adverse reactions, ranging from mild to severe.

Common Side Effects: - Injection site pain - Mild hyperkalemia - Nausea - Dizziness

Serious or Rare Side Effects: - Severe hyperkalemia - Cardiac arrhythmia - Anaphylactic reaction

When using Kaliumklorid Sad, clinicians should observe specific precautions to ensure patient safety.

- Assess serum potassium before administration: confirm deficiency and avoid overcorrection. - Adjust dose in renal impairment: reduced clearance may increase risk of hyperkalemia. - Monitor ECG during rapid infusion: detect emerging arrhythmias promptly. - Avoid concurrent IV potassium solutions: prevent additive potassium load. - Use caution with digoxin therapy: elevated potassium can alter digoxin toxicity. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

Potassium chloride can interact with several medications, influencing potassium levels or cardiac function.

Major Interactions (Avoid): - ACE inhibitors: may cause additive hyperkalemia. - Potassium‑sparing diuretics: increase risk of dangerous potassium excess. - Trimethoprim‑sulfamethoxazole: can elevate serum potassium.

Moderate Interactions (Monitor Closely): - Digoxin: altered potassium may affect digoxin toxicity. - Lithium: potassium shifts can modify lithium clearance.